Cannabinoids for Cancer: ft. MSc BioChemist Ben Euhus

How Minor Cannabinoids are Made: Synthetic vs Biosynthetic ft. Shane Johnson: Synthesis, a process that may sound complex, is actually quite common in our daily lives. From the production of everyday items like Advil, organic milk, citric acid, to the creation of vitamins A and D, and multivitamins, synthesis is a key player. Why does this realization often provoke a negative reaction? Perhaps it's because there's a desire for clean, safe, and consistent natural products, especially when they originate from plants. Surprisingly, synthesis enhances our ability to deliver such products. This week, we're joined by Shane Johnson to delve into the following topics: How minors are manufactured, synthetic vs. biosynthetic Upcoming Minors to keep an eye on Novel APIs & Analogs About Dr. Shane Johnson Dr. Shane Johnson’s career has focused principally on offering strategic business advisory services to companies in the biotechnology and healthcare sectors. His work has included gui by The Dime

54 min listen

Unveiling the $4 Million Problem: Hop Latent Viroid's Impact on Cannabis Cultivation ft. Dr. Tassa Saldi: The economic impact of Hop Latent Viroid on cannabis cultivation remains a significant concern, costing the industry millions annually. In our latest episode, we dive into proactive measures to combat this threat with Dr. Tassa Saldi. Affecting ~80% of cultivators, Dr. Saldi sheds light on the necessity of proactively testing. While some may question the need for proactive testing, likening it to insurance, the truth is stark: overlooking this crucial step could result in catastrophic consequences for your crops and business. Join us as we explore: The nuances of Hop Latent Viroid Strategies for proactive testing Assessing the value of a mother plant Identifying other pathogens demanding attention in cannabis cultivation Guest Links: https://tumigenomics.myshopify.com/ https://www.linkedin.com/in/tassa-saldi-phd-03174a179/ https://twitter.com/tumigenomics https://www.inst by The Dime

46 min listen

Aaron Nosbich Reveals BRĒZ Marketing Secrets: A Beverage Exploding Toward $20 Million: BRĒZ immediate success is a testament to the power of a skilled team, a great product, and incredible marketing. A little over a year since its inception, BRĒZ hockey stick trajectory is undeniable and worthy of emulation. When executed perfectly, marketing becomes more than just a line item on a P&L; it becomes a tool with unlimited potential. BRĒZ ability to connect with consumers on a personal level and address all hidden potential questions and concerns reflects textbook marketing prowess that would earn the approval of industry legends like Gary Albert or David Ogilvy. The storytelling marketing strategy isn't an Ad but a friendly, informative guide. Educating consumers about an alternative to alcohol minimizes the intimidation factor and highlights the product's benefits, such as its quick onset and ability to eliminate brain fog. The true beauty of Bez's marketing lies in its authentic sto by The Dime

53 min listen

Paul F. Austin on Exploring Psychedelics: Creativity, Hidden Benefits, Microdosing, and Retreats by The Dime

51 min listen

Chris Fontes: Cannabis is Already Legal - Hemp vs Cannabis: The 2018 Farm Bill has undeniably reshaped the cannabis industry, blurring lines and unlocking opportunities between hemp and cannabis. This episode delves into the nuanced differences and similarities between these two facets of the cannabis world. Chris Fontes shares his insights to dissect the complex web of legislation, the evolving roles of MSOs and Big Pharma, and the boundless opportunities emerging from regulatory challenges. Discover how today's cannabis entrepreneurs are utilizing the interpretation of opportunities to transform obstacles into avenues for innovation and sector growth. This week, we sit down with Chris Fontes to discuss the following: Hemp vs. Cannabis: Exploring Opportunities, Differences, and Challenges. Impact of the 2018 Farm Bill: What's next for legislation and how it shapes the industry. MSOs, Big Pharma's influence, and more. About Chris Fontes: Chris Fontes, the Founder and CEO of High Sp by The Dime

60 min listen

Anthony Coniglio: Capital Injections, REITs, Location Opportunities: Capital in the cannabis industry is not just scarce; it's a puzzle. Have you come across terms like sale-leaseback and triple net lease in press releases and earnings reports yet find yourself questioning their actual mechanics? What's more, the implications for companies opting for these leasebacks might be more surprising than you think. And from the perspective of a REIT company, how do they pinpoint opportunities, especially when evaluating location and market potential? These insights are valuable for understanding the framework for decision-making, both short and long-term. This week, we sit down with Anthony Coniglio to discuss the following: What are a sale-leaseback and a triple net lease? Portfolio diversification, tenant quality, and location choice. Strategies for injecting capital into cannabis companies. Guest Links: https://www.linkedin.com/in/coniglioanthony/ https://www.newlake.com/ http by The Dime

46 min listen

Seth Yakatan: Are you Ready for the Next Wave of M&A in Cannabis: Major industry behemoths like P&G or British Tobacco are setting their sights on the cannabis industry, poised to disrupt and seamlessly integrate. In this rapidly evolving landscape, are you engaging in crucial internal and external conversations in anticipation of the next wave? This week, we sit down with Seth Yakatan to discuss the following: Founders and Companies set up for major exits. Secrets to a Profitable, Cash-Flowing Operation Build to Sell vs Build to Compete How CPG giants are eyeing cannabis for potential mergers. Guest Links Katan Associates International | Corporate Strategy & Merchant Banking | United States https://www.linkedin.com/company/katan-associates-international/ https://www.linkedin.com/in/seth-yakatan/ Follow us: Our Links. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. 8th Revolution Cannabin by The Dime

58 min listen

Todd Harrison: Chewing Through Noise in The Cannabis Industry with a Focus on Catalysts: Amidst the breaking down the walls of prohibition, it's clear that change is underway. The speed at which the cannabis industry is evolving is hard to truly grasp unless you step back and appreciate how much has altered in the last 10 years compared to the previous 100. While issues and unknowns persist, incremental progress with accelerated catalysts is gaining momentum, making one thing extremely clear: The genie is unlikely to go back into the bottle. This week, we sit down to reflect on the past with an understanding of what lies ahead. Todd Harrison joins us to discuss the following: Economic Opportunity Catalysts S3, Safer, Election, States Under Recognized Cannabinoids Medical Benefits And so much more Guest Links https://toddharrison.substack.com/ https://www.cb1cap.com/ https://twitter.com/CB1Cap https://twitter.com/todd\_harrison About CB1 Capital We believe the cannabis plan by The Dime

22 min listen

$Todd Harrison: Chewing Through Noise in The Cannabis Industry with a Focus on Catalysts: Amidst the breaking down the walls of prohibition, it's clear that change is underway. The speed at which the cannabis industry is evolving is hard to truly grasp unless you step back and appreciate how much has altered in the last 10 years compared to the previous 100. While issues and unknowns persist, incremental progress with accelerated catalysts is gaining momentum, making one thing extremely clear: The genie is unlikely to go back into the bottle. This week, we sit down to reflect on the past with an understanding of what lies ahead. Todd Harrison joins us to discuss the following: Economic Opportunity Catalysts S3, Safer, Election, States Under Recognized Cannabinoids Medical Benefits And so much more Guest Links https://toddharrison.substack.com/ https://www.cb1cap.com/ https://twitter.com/CB1Cap https://twitter.com/todd\_harrison About CB1 Capital We believe the cannabis plan$

Boris Jordan on Curaleaf's European Strategy: Building Coca-Cola of Cannabis: "Great companies were never built by conservative leaders. Great companies were built by risk-takers." Deeply ingrained in Curaleaf's DNA is the ability to navigate the unknown ahead of opportunities. Timing these events is nearly impossible, but having the foresight and strategic resources in place when the opportunity strikes can change the game. For visionaries like Boris Jordan, being early in markets like Germany can be challenging for everyone to see until recent developments materialize. The US and European cannabis markets operate very differently, and Curaleaf is in a prime position to secure an untapped market share twice the size of the US. This week, we sit down with Boris Jordan to discuss the following: Unique Market Differences: Europe vs US Educating Institutional Investors: What does that conversation look like inside the room? Breakdown of the German Market, Hint toward Asia And so mu by The Dime

52 min listen

Pablo Zuanic on Cannabis Stocks: Institutional Strategies for Retail Investors: Investing in cannabis stocks is not for the faint of heart. It's common to see these stocks pop only to retrace their gains quickly. Understanding the implications and the strategies that institutional investors will use as they enter the sector, currently dominated by retail, could be a generational difference-maker for so many. This week, we speak with Pablo Zuanic to discuss the following: Cannabis Long-Term Investments: Navigating Market Nuances 280E Removal, Germany implications So much more About Pablo Zuanic Pablo Zuanic is a well-known and highly rated consumer sector equity analyst, most recently following the cannabis and psychedelics sector. Over the past four years he launched coverage of over 35 companies (MSOs, LPs, CBD, MJ ancillary, mental health clinics), kept close track of sectoral trends, and followed the reform process in the US and elsewhere. Pablo is the Managing Partner by The Dime

56 min listen

Rick Bashkoff: Why Cannabis Needs Unique Software Solutions: Companies obsessed with solving specific pain points always win. The cannabis industry, with its unique challenges, demands tailor-made software solutions. Software that guides critical decisions forms the company's foundational backbone. An unwavering dedication to profoundly understanding customer challenges and the agility to create nimble, value-focused software solutions is indispensable and poised to disrupt any incumbent. This week, we sit down with Rick Bashkoff to discuss: LitAlerts, CannaVerisions & the Origin from Pain to Solution The Critical Role of Accurate Data for Success Building Software Solutions for the Cannabis Sector The Readiness of the Cannabis Industry for AI https://www.litalerts.com/ https://cannaversions.com/ https://www.receptivecap.com/ https://www.linkedin.com/in/rickbashkoff/ Lit Alerts:Founded in 2021 by a dispensary owner and an online marketing executive, we are a lean team built by The Dime

62 min listen

House of Puff Evolves: Introducing The Spritz: Creating trust is foundational in authentic brand development. The transition from content creator visibility to tangible product offerings has become a pivotal strategy among leading global brands. The success stories of Mr. Beast's Feastables and Logan Paul & KSI's Prime underscore the significance of integrating your brand's identity into every aspect of your product. This approach ensures meticulous packaging and thoughtful design, essential for cultivating a captivating customer experience. House of Puff has recently unveiled its first adult-use product, marking a pivotal moment in their journey. This week, we connect with the masterminds behind House of Puff, Kristina Adduci & Holly Hager, to explore: The Evolution from Content Creator to Product Launch Low Potency Products The Why behind their new launch And much more About House of Puff: House of Puff is a women-owned and Latina-led company that’s based in the heart of New by The Dime

44 min listen

Gabe Mendoza: Driving 4Front Ventures Revenue Growth through Innovation from Ideas to Opportunities: Operating since 2011 comes with an enormous amount of experience and scars. Navigating the turbulence and keeping an eye on what's essential while scaling your organization is no small feat. Identifying new hidden revenue opportunities is the first challenge, but capitalizing on those opportunities, given the plethora of cannabis challenges, is an entirely different beast. This week, we sit down with Gabe Mendoza, EVP of Revenue for 4Front Ventures, to discuss the following: Introducing "The Hunt" Leveraging Highly Competitive Markets for Product Testing Turning Experience into Revenue Opportunity About 4Front ventures Established in 2011, we’re a leading force in North America’s cannabis industry. With over 600 skilled professionals across key states, we’re constantly refining our craft and advancing the industry. Our track record showcases our ability to thrive at scale in comp by The Dime

55 min listen

Kim Rivers Discusses Trulieve Preparing for Florida's ~$6 Billion Opportunity by The Dime

61 min listen